Markets and the feds and beyond. Lets get to andrew with breaking news on valeant. Another turn, the drug maker says its ending its relationship due to the Specialty Pharmacy business practices. The company saying it has lost confidence in the ability to operate in a manner acceptable to valeant. In response it said it would shutdown operations as soon as possible. Cvs health care also dropped them. Cvs saying it will no longer use services after an audit found evidence of noncompliance. Now valeant has been facing a lot of pressure and is facing federal scrutiny as well on the drug pricing and distribution policies so this is a big issue. Also activist investor and one of the largest shareholders expected to hold a Conference Call discussing his firms investment in valeant. Philidor represented somewhere between 5 and 10 depending on whose math you were doing for valeant. This will be a direct hit on the company but does seem to be suggesting they take some steps. Another story, one o
New-york
United-states
Tokyo
Japan
Texas
Mount-washington
Kentucky
China
Boston
Massachusetts
California
Washington